ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 195 filers reported holding ANI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $488,000 | -32.9% | 14,882 | -28.2% | 0.00% | -66.7% |
| Q2 2021 | $727,000 | +53.1% | 20,732 | +57.6% | 0.00% | 0.0% |
| Q1 2021 | $475,000 | +114.9% | 13,152 | +92.2% | 0.00% | -25.0% |
| Q2 2020 | $221,000 | -77.3% | 6,842 | -56.7% | 0.00% | -33.3% |
| Q4 2019 | $975,000 | -31.7% | 15,810 | -9.0% | 0.01% | -57.1% |
| Q2 2019 | $1,428,000 | +136.8% | 17,372 | +103.4% | 0.01% | +133.3% |
| Q1 2019 | $603,000 | -8.1% | 8,542 | -41.4% | 0.01% | -25.0% |
| Q4 2018 | $656,000 | +196.8% | 14,572 | +283.9% | 0.01% | +100.0% |
| Q1 2018 | $221,000 | -83.5% | 3,796 | -81.7% | 0.00% | -82.6% |
| Q4 2017 | $1,337,000 | +369.1% | 20,750 | +240.3% | 0.02% | +283.3% |
| Q2 2017 | $285,000 | +14.9% | 6,097 | +49.1% | 0.01% | -40.0% |
| Q4 2016 | $248,000 | -4.2% | 4,088 | +4.7% | 0.01% | -41.2% |
| Q3 2016 | $259,000 | -58.8% | 3,904 | -79.1% | 0.02% | -65.3% |
| Q1 2016 | $628,000 | +27.1% | 18,645 | +70.4% | 0.05% | -9.3% |
| Q4 2015 | $494,000 | – | 10,945 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |